Wieslaw Jakubowski
Pediatrics · Corpus Christi, TXNPI 1164512075
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 119 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 13.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,415 and has fallen 75.8% since, to $342 in 2025. Among pediatrics clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 119 payments — averaging $43.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ironshore Pharmaceuticals Inc.$693
- GSK$397
- Biogen$377
- Tris Pharma Inc$346
- Travere Therapeutics, Inc.$345
- Corium, LLC$319
- plus $3K from 24 others
Across 73 payments — averaging $68,788 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novavax Inc$4.9M
- Merck$59K
- Modernatx, Inc.$35K
- Sanofi Pasteur Inc.$11K
What the payments were for
- Food & beverage$5,182100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ironshore Pharmaceuticals Inc. | 19 | $693 |
| GSK | 11 | $397 |
| Biogen | 6 | $377 |
| Tris Pharma Inc | 13 | $346 |
| Travere Therapeutics, Inc. | 3 | $345 |
| Corium, LLC | 10 | $319 |
| AstraZeneca | 3 | $299 |
| Pfizer | 9 | $269 |
| Regeneron Healthcare Solutions, Inc. | 2 | $241 |
| Collegium Pharmaceutical, Inc. | 4 | $185 |
| Supernus Pharmaceuticals, Inc. | 8 | $183 |
| Mirum Pharmaceuticals, Inc. | 2 | $172 |
| Merck | 3 | $142 |
| Pharming Healthcare, Inc. | 1 | $121 |
| Novartis | 2 | $109 |
| Teva Pharmaceuticals USA, Inc. | 1 | $105 |
| Phadia US Inc. | 2 | $104 |
| Ultragenyx Pharmaceutical Inc. | 1 | $100 |
| Kyowa Kirin, Inc. | 1 | $100 |
| Shire North American Group Inc | 1 | $97 |
| Sanofi Pasteur Inc. | 5 | $91 |
| Biofire Diagnostics, LLC | 1 | $90 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $74 |
| Genentech, Inc. | 1 | $73 |
| Vertical Pharmaceuticals, LLC | 3 | $62 |
| Alk-abello, Inc | 1 | $28 |
| Neos Therapeutics, LP | 1 | $17 |
| Adlon Therapeutics L.p. | 1 | $15 |
| Rhodes Pharmaceuticals L.p. | 1 | $14 |
| Mission Pharmacal Company | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DUPIXENT$241
- (815) Thiola$240
- JORNAY PM$233
- Jornay PM 20mg capsules (Bottle of 100)$229
- BEXSERO$201
- JOENJA$121
- Dyanavel XR$115
- Quillivant$115
- Quillichew ER$115
- TRUMENBA$111
- AJOVY$105
- (820) Cholbam$105
- VAXNEUVANCE$105
- Azstarys$102
How this compares
$5,182 in reported general payments places this provider in the 95th percentile of 5,361 pediatrics providers in Texas.
Other pediatrics in Corpus Christi
- Jennifer Amaral RamosCorpus Christi$15K
- Pedro PiedraHouston$729K
- Jason RiehsFrisco$216K
- Ivonne Sahagun-CarreonNew Braunfels$168K
- Angela ScheuerleDallas$118K
- Dianna BurnsSan Antonio$100K
- Jason TerkKeller$93K
- Vernon SuttonHouston$90K
- Laura ScalfanoPlano$74K
- Patricia AmersonSan Antonio$73K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.